Baixar PDF

Outros usuários também visualizaram estes artigos

Lower doses of dacarbazine (modified BEACODD) as a safer strategy with equal effectiveness in an intensive treatment protocol of Hodgkin's lymphoma: a preliminary retrospective analysis of a single public center in Brazil Larissa Hilario Dulley; Arthur Gomes Oliveira Braga; Guilherme Garcia Rodrigues; Sergio Costa Fortier; Carlos Sérgio Chiattone; Talita Maira Bueno da Silveira;
Hematol Transfus Cell Ther. 2025;47:
Diagnosis and treatment of chronic lymphocytic leukemia: 2025 recommendations of the Brazilian Group of Chronic Lymphocytic Leukemia of the Brazilian Association of Hematology and Hemotherapy (ABHH) Carlos Sérgio Chiattone; Fernanda de Morais Marques; Valeria Buccheri; Mihoko Yamamoto; Sergio Costa Fortier; Maura Rosane Valerio Ikoma-Colturato; Nelson Hamerschlak; Vera Lucia de Piratininga Figueiredo; Talita Maira Bueno da Silveira; Abel Costa; Dani Laks; Rony Schaffel; Wolney Gois Barreto; Adriana Scheliga; Pedro Amoedo Fernandes; Samir Kanaan Nabhan; Rafael Dezen Gaiolla; Matheus Vescovi Gonçalves; Danielle Leão Cordeiro de Farias; Glaciano Ribeiro; Marcelo Pitombeira de Lacerda; Celso Arrais-Rodrigues;
Hematol Transfus Cell Ther. 2025;47:
Peripheral lymphocyte subsets as predicting factors for molecular recurrence after imatinib discontinuation in a phase 2 imatinib discontinuation trial in patients with chronic myeloid leukemia Arthur Gomes Oliveira Braga; Katia Borgia Barbosa Pagnano; Marina Dal'Bó Pelegrini Campioni; Ana Beatriz Pascoal Lopes; Gislaine Oliveira Duarte; Konradin Metze; Irene Lorand-Metze;
Hematol Transfus Cell Ther. 2024;46:268-72